Reference
Zhang X, et al. Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-beta in Relapsing-Remitting Multiple Sclerosis. CNS Drugs : 19 Oct 2014. Available from: URL: http://doi.org/10.1007/s40263-014-0207-x
Rights and permissions
About this article
Cite this article
Dimethyl fumarate the dominant option in RRMS. PharmacoEcon Outcomes News 715, 16 (2014). https://doi.org/10.1007/s40274-014-1674-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1674-5